About
Barron's senior managing editor Lauren R. Rublin and healthcare reporter Josh Nathan-Kazis speak with RBC analyst Luca Issi about gene therapy and other innovations in biotechnology - and the best biotech stocks to buy now. Plus, an update on Covid vaccines and treatments.

WEBINAR ENDED
Presenters
1624389475-3b540ae2b607b094
Lauren Rublin
Senior Managing Editor
Lauren R. Rublin is the senior managing editor at Barron's, overseeing Roundtables and Special Projects. She previously worked in book publishing, and at Fairchild Publications and Time Inc.
1624389477-1c8f0f40e34bb821
Josh Nathan-Kazis
Health-care Industry Reporter , Barron's
Josh Nathan-Kazis is a reporter at Barron's, covering the healthcare industry. He is a former staff writer at the Forward, where he investigated nonprofits, covered local and national politics, and wrote about the institutions of the American Jewish community.
1624389478-f1ad4b7a515c082f
Luca Issi
Analyst, RBC
Luca Issi joined RBC Capital Market in 2020, and is covering Biotech. Prior to RBC, he was an investor at Bain Capital Life Sciences, where he led private and public investments across biopharmaceutical, medical device, specialty pharma and tools & diagnostics. Prior to Bain, he worked in equity research at Cowen and Company, where he covered large cap pharmaceutical companies. He received his PhD in Biotechnology from Worcester Polytechnic Institute and graduated summa cum laude in Biotechnology from the University of Milan (MS) and the University of Varese (BS).
Register To Watch Recording
Full name*
Email Address*
Seniority*
Company*
Have a question for the Speaker? Submit here.
Marketing Permission
By registering, I agree to receive communications regarding this event series and receive future emails regarding Barron's Group events. I understand that I can unsubscribe at any time by clicking the unsubscribe link in the footer of our emails, or by replying to our emails and asking to be unsubscribed. For more information, please read our privacy notice.
Privacy Notice
✓ Yes, I would like to receive communications from Barron's Group.
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.